Vishva M. Dixit is presently Vice President of Early Discovery Research at Genentech Inc.
He has made many contributions to biomedicine and his work on cell death and inflammation is
prominent in introductory textbooks of biology and medicine.

After beginning his career as a physician in Kenya, Vishva moved to the United States where he
trained as a Pathologist at Washington University, St. Louis. Prior to his current position at
Genentech, he was Professor of Pathology at the University of Michigan. Dixit’s pioneering
studies defined the biochemical framework illuminating many of the key components of the cell
death pathway. He identified numerous proteins in the cell death cascade and determined how
they functioned at a molecular level. More recent work has involved the role of cell death
pathways in inflammation.

Vishva’s groundbreaking research has resulted in numerous honors including:

William B. Coley Award for Distinguished Research in Basic and Tumor Immunology
Dr A.H. Heineken Prize for Medicine
Vilcek Prize in Biomedical Science
Member, National Academy of Sciences
Foreign Member of the Royal Society (ForMemRS)
Member, National Academy of Medicine
Fellow, American Academy of Arts and Sciences
Foreign Member of The Royal Netherlands Academy of Arts and Sciences
Foreign Member, European Molecular Biology Organization